Rebalix
iShares · sheet of 5 September 2026
iShares · sheet of 5 September 2026ETF sheet · official issuer and register data
iShares MSCI USA Swap UCITS ETF GBP Hedged
MUSG · IE000DLDNVK1 · class Hedged · GBP · domicile Ireland
Equity · United States · Large & mid capGBP-hedged share classSFDR art. 6
Index tracked: MSCI USA Index
- TER
- 0.05%+ trans. 0.02%
- Fund size
- 9 m EUR
- Tracking difference
- +0.00%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Synthetic (swap)
- Income
- Distributingsemi-annual
Launch 26 Mar 2025 · costs from the KID as of 2 Sept 2026 · 521 securities held
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 7 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the net total return of the MSCI USA Index, the Fund’s benchmark index (Index). The Fund is passively managed and invests in financial derivative instruments (FDIs). In particular, it will enter into unfunded total return swaps in order to achieve its investment objective. A swap agreement is typically used to achieve a specified return determined by an underlying such as a…
Performance since series start (in euro) — base 100
26 Mar 2025 → 31 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +20.6% |
| 3 years | series too young |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +32.3% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 12.93% | 12.93% | — |
| Max drawdown | −9.26% | −9.26% | — |
| Sharpe | 1.28 | 1.28 | — |
| Sortino | 1.86 | 1.86 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · MUSG · IE000DLDNVK11
RebalixMUSG · IE000DLDNVK1 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · declared by the issuer
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +0.00% | +0.00% | +0.00% |
| 2024 | +0.00% | +0.00% | +0.00% |
| 2023 | +0.00% | +0.00% | +0.00% |
| 2022 | +0.00% | +0.00% | +0.00% |
| 2021 | +0.00% | +0.00% | +0.00% |
Distributions · per share, in GBP
Frequency: semi-annual · last 12 months: 0.04 GBP (0.60% of NAV) · 11 months of history: not a full year · last ex-date 16 Apr 2026
| Year | Payments | Total (GBP) |
|---|---|---|
| 2026 | 1 | 0.02 |
| 2025 | 1 | 0.02 |
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 31 Aug 2026 · 521 securities · top-10 weight = 132.9%
| Top holdings | Weight |
|---|---|
| 100.0% | |
| 4.6% | |
| 4.6% | |
| 4.4% | |
| 3.5% | |
| 3.5% | |
| 3.2% | |
| 3.2% | |
| 3.1% | |
| 2.9% |
Listing venues
ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE000DLDNVK1
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE000DLDNVK1
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · MUSG · IE000DLDNVK12